Benitec Biopharma Inc. (BNTC) Stock Analysis

Free AI-powered analysis and research for Benitec Biopharma Inc. stock

Sector: Healthcare

Full BNTC report

Benitec Biopharma Inc. (BNTC) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

📰 Latest Update

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301

Wed, October 28, 2026 at 12:00 PM UTC 4 min read

Benitec Biopharma (BNTC) announced positive interim results from its Phase 1b/2a trial for high-dose BB-301, showing promising efficacy and safety. The study also reported sustained improvements with the low-dose BB-301 treatment. These developments are significant for investors as they bolster the company's potential in the gene therapy market and may pave the way for future advancements and partnerships.

Read full article →

People also watch